Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: A time and motion study

Author:

Rog David,Brownlee Wallace,Carod-Artal Francisco Javier,Kalra Seema,Barker Noreen,Lowndes Claire,Pendlebury Jessica,Leclerc Stephanie,Amin Amerah,Ashton Luke,Evans Hannah,De Cock ErwinORCID

Funder

Merck Healthcare KGaA

Merck

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference28 articles.

1. Aventis Pharma Limited, 2022. LEMTRADA 12 mg concentrate for solution for infusion, Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/5409/smpc#gref (Accessed July 2022).

2. Biogen Netherlands B.V, 2022. TYSABRI 300 mg concentrate for solution for infusion, Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/18447/SPC/TYSABRI+300+mg+concentrate+for+solution+for+infusion/#gref (Accessed July 2022).

3. An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries;Body;Support. Care Cancer,2017

4. Unit Costs of Health and Social Care 2019;Curtis,2019

5. Unit Costs of Health and Social Care 2020;Curtis,2020

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3